A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer

Jeremy Chien, Julie Staub, Shou Ih Hu, Michele R. Erickson-Johnson, Fergus J. Couch, David I. Smith, Robert M. Crowl, Scott H. Kaufmann, Viji Shridhar

Research output: Contribution to journalArticlepeer-review

134 Scopus citations


We report here that HtrA1, a candidate tumor suppressor, is downregulated in ovarian cancer. Expression of HtrA1 is downregulated in five of seven ovarian cancer cell lines. In total, 59% of primary ovarian tumors have either a complete absence or markedly reduced levels of HtrA1 expression compared to the brushings of ovarian surface epithelium. Primary ovarian tumors show high frequencies of loss of an allele at microsatellite markers near htrA1 locus on 10q26. Downregulation of HtrA1 in SKOV3 by antisense transfection promotes anchorage-independent growth, while exogenous expression of HtrA1 in OV202 induces cell death. HtrA1-induced cell death is not inhibited by the broad caspase inhibitor, zVAD(O-Me)fmk, but instead reflects serine protease activity associated with HtrA1. These observations raise the possibility of HtrA1 as a candidate tumor suppressor involved in promoting serine-protease-mediated cell death and that downregulation of HtrA1 in ovarian cancer may contribute to malignant phenotype.

Original languageEnglish (US)
Pages (from-to)1636-1644
Number of pages9
Issue number8
StatePublished - Feb 26 2004


  • Downregulation
  • HtrA
  • Loss of heterozygosity
  • Ovarian cancer
  • Serine protease

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer'. Together they form a unique fingerprint.

Cite this